At meeting held on 06 December 2018
The Board of Directors of Alembic Pharmaceuticals at its meeting held on 06 December 2018 has inter-alia (i) approved the Issue of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 500 crore on Private Placement Basis under a shelf disclosure document in multiple tranches and (ii) Constituted NCD Committee for issue and allotment of NCDs.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content